1 Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 2021; 127: 3029-3030
2 Sung H, Ferlay J, Siegel RL et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians 2021; 71: 209-249
3 Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet (London, England) 2021; 398: 535-554
4 Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2015; 10: 1240-1242
5 Schabath MB, Cote ML. Cancer Progress and Priorities: Lung Cancer. Cancer Epidemiol Biomarkers Prev 2019; 28: 1563-1579
6 Bray F, Ferlay J, Soerjomataram I et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2018; 68: 394-424
7 Sculier JP. [Management of resectable non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party]. Revue medicale de Bruxelles 2014; 35: 134-139
8 Paik PK, Pillai RN, Lathan CS, Velasco SA, Papadimitrakopoulou V. New Treatment Options in Advanced Squamous Cell Lung Cancer. Am Soc Clin Oncol Educ Book 2019; 39: e198-e206
9 Ojlert AK, Halvorsen AR, Nebdal D et al. The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery. Mol Oncol 2019; 13: 1166-1179
10 Zhang R, Chen C, Dong X et al. Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects. Chest 2020; 158: 808-819
11 Amin MB, Greene FL, Edge SB et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging. CA: a cancer journal for clinicians 2017; 67: 93-99
12 Ohori Tatsuo G, Riu Hamada M, Gondo T, Hamada R. [Nomogram as predictive model in clinical practice]. Gan to kagaku ryoho Cancer & chemotherapy 2009; 36: 901-906
13 Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 2008; 26: 1364-1370
14 Cronin KA, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. Cancer 2014; 120 Suppl 23: 3755-3757
15 Detterbeck FC. The eighth edition TNM stage classification for lung cancer: What does it mean on main street? The Journal of thoracic and cardiovascular surgery 2018; 155: 356-359
16 Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. The Lancet Oncology 2015; 16: e173-e180
17 Li W, Gao LN, Song PP, You CG. Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma. Aging 2020; 12: 3558-3573
18 Liu Y, Wu L, Ao H et al. Prognostic implications of autophagy-associated gene signatures in non-small cell lung cancer. Aging 2019; 11: 11440-11462
19 Xu F, Lin H, He P et al. A TP53-associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma. Oncoimmunology 2020; 9: 1731943
20 You H, Teng M, Gao CX et al. Construction of a Nomogram for Predicting Survival in Elderly Patients With Lung Adenocarcinoma: A Retrospective Cohort Study. Frontiers in medicine 2021; 8: 680679
21 Jia B, Zheng Q, Wang J et al. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database. BMC Cancer 2020; 20: 666
22 Scarpace SL. Metastatic squamous cell non-small-cell lung cancer (NSCLC): disrupting the drug treatment paradigm with immunotherapies. Drugs in context 2015; 4: 212289
23 Zhang J, Xu J, Jin S et al. The development and validation of a nomogram for predicting brain metastases in lung squamous cell carcinoma patients: an analysis of the Surveillance, Epidemiology, and End Results (SEER) database. Journal of thoracic disease 2021; 13: 270-281
24 Zheng R, Gu X, Wang M, Hu M, Xu H. Nomograms to Predict Survival in Patients with Lung Squamous Cell Cancer: A Population-Based Study. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2019; 86: 336-344
25 Li M, Zhan C, Sui X et al. A Proposal to Reflect Survival Difference and Modify the Staging System for Lung Adenocarcinoma and Squamous Cell Carcinoma: Based on the Machine Learning. Frontiers in oncology 2019; 9: 771
26 Pan LY, Peng LP, Xu C et al. Predictive factors of cough after uniportal video-assisted thoracoscopic pulmonary resection. Journal of thoracic disease 2020; 12: 5958-5969
27 Li C, Jiang C, Gong J et al. A CT-based logistic regression model to predict spread through air space in lung adenocarcinoma. Quantitative imaging in medicine and surgery 2020; 10: 1984-1993
28 Zhou YK, Li XP, Yin JY et al. Association of variations in platinum resistance-related genes and prognosis in lung cancer patients. Journal of Cancer 2020; 11: 4343-4351
29 Pilleron S, Maringe C, Charvat H et al. Age disparities in lung cancer survival in New Zealand: The role of patient and clinical factors. Lung cancer (Amsterdam, Netherlands) 2021; 157: 92-99
30 Arnold M, Rutherford MJ, Bardot A et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. The Lancet Oncology 2019; 20: 1493-1505
31 Katcoff H, Wenzlaff AS, Schwartz AG. Survival in women with NSCLC: the role of reproductive history and hormone use. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2014; 9: 355-361
32 Cheng TY, Cramb SM, Baade PD et al. The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016; 11: 1653-1671
33 Eskander MF, Schapira EF, Bliss LA et al. Keeping it in the family: the impact of marital status and next of kin on cancer treatment and survival. American journal of surgery 2016; 212: 691-699
34 Aizer AA, Chen MH, McCarthy EP et al. Marital status and survival in patients with cancer. J Clin Oncol 2013; 31: 3869-3876
35 Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83: 584-594
36 Rosen JE, Keshava HB, Yao X et al. The Natural History of Operable Non-Small Cell Lung Cancer in the National Cancer Database. The Annals of thoracic surgery 2016; 101: 1850-1855
37 Dhanasopon AP, Salazar MC, Hoag JR et al. Fate of Pneumonectomy Patients Variably Captured by Non-Small Cell Lung Cancer Staging System. The Annals of thoracic surgery 2017; 104: 1829-1836
38 Gezer S, Oz G, Findik G et al. Sleeve resections for squamous cell carcinoma of the lung. Heart, lung & circulation 2010; 19: 549-554
39 Bertsimas D, Dunn J, Velmahos GC, Kaafarani HMA. Surgical Risk Is Not Linear: Derivation and Validation of a Novel, User-friendly, and Machine-learning-based Predictive OpTimal Trees in Emergency Surgery Risk (POTTER) Calculator. Annals of surgery 2018; 268: 574-583